Sanguine Media
In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was under ₹1 Cr in both quarters (compared with Jun 2025). Promoters held 0.00% of Sanguine Media in Jun 2026, unchanged from Mar 2026.
Peer Comparison
Consumer Discretionary › Entertainment › Film Production, Distribution & Exhibition
| ₹1,488.40 | 32.88 | 14,616 Cr | 1.98 | 0.00% | 2.39% | 7.24% | 7,192 Cr | 443 Cr | |
| — | — | 1,600 Cr | 23.05 | 0.04% | 10.36% | 15.51% | 27 Cr | 7 Cr | |
| ₹240.00 | — | 458 Cr | 3.41 | 0.00% | 19.42% | 23.50% | 42 Cr | 10 Cr | |
| — | 147.56 | 387 Cr | 2.62 | 0.00% | 2.12% | 2.00% | 19 Cr | 3 Cr | |
Sanguine Media (this company) | — | — | — | — | — | — | — | 0 Cr | -0 Cr |
| Median 5 companies | ₹864.20 | 90.22 | 1,029 Cr | 3.02 | 0.00% | 6.38% | 11.38% | 27 Cr | 7 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 3 companies are not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of -0.07% over last 3 years.
- Company has high debtors of 55,845 days.
Technical Indicators
Oscillators
Neutral
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0.06 | 0.04 | 0 | 0 | 0.02 | 0.05 | 0.02 | 0 | 0 | 0.02 | 0.01 | 0 |
| Expenses | 0.03 | 0.1 | 0.04 | 0.13 | 0.04 | 0.09 | 0.1 | 0.05 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| Operating Profit | -0.03 | -0.04 | 0 | -0.13 | -0.04 | -0.07 | -0.05 | -0.03 | -0.03 | -0.03 | 0 | -0.01 | -0.02 |
| OPM % | — | -66.67% | 0% | — | — | -350% | -100% | -150% | — | — | 0% | -100% | — |
| Other Income | 0.05 | 0.01 | 0 | -3.96 | 0.03 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0.02 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.02 | -0.03 | 0 | -4.09 | -0.01 | -0.07 | -0.05 | -0.03 | 0 | 0 | 0 | -0.01 | 0 |
| Tax % | 0% | 0% | — | 0% | 0% | 0% | 0% | 0% | — | — | — | 0% | — |
| Net Profit | 0.01 | -0.03 | 0 | -4.09 | -0.01 | -0.07 | -0.05 | -0.03 | 0 | 0 | 0 | -0.01 | 0 |
| EPS (₹) | 0 | 0 | 0 | -0.36 | 0 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.5 | 32.79 | 5.85 | 10.22 | 0.41 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 | 0.03 |
| Expenses | 6.93 | 32.26 | 5.85 | 10.12 | 0.47 | 0.09 | 1.97 | 0.05 | 0.15 | 0.29 | 0.28 | 0.1 | 0.09 |
| Operating Profit | 0.57 | 0.53 | 0 | 0.1 | -0.06 | -0.09 | -1.97 | -0.05 | -0.15 | -0.19 | -0.28 | 0 | -0.06 |
| OPM % | 7.6% | 1.62% | 0% | 0.98% | -14.63% | — | — | — | — | -190% | -133.33% | 0% | -200% |
| Other Income | 0.29 | 0.26 | 0.3 | 0.16 | 0.04 | -0.13 | 0.05 | 0.04 | 0.13 | -3.91 | 0.12 | 0 | 0.05 |
| Interest | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.63 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.23 | 0.32 | 0.3 | 0.22 | -0.02 | -0.22 | -1.92 | -0.01 | -0.02 | -4.1 | -0.16 | 0 | -0.01 |
| Tax % | 13.04% | 28.12% | 20% | 22.73% | 0% | 0% | 0% | 0% | -10150% | 0% | 0% | — | — |
| Net Profit | 0.2 | 0.23 | 0.24 | 0.17 | -0.02 | -0.23 | -1.92 | -0.01 | 2.01 | -4.1 | -0.16 | 0 | -0.01 |
| EPS (₹) | 0.02 | 0.02 | 0.02 | 0.01 | 0 | -0.02 | -0.17 | 0 | 0.18 | -0.36 | -0.01 | 0 | 0 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 114 | 114 | 114 | 114 | 114 | 114 | 114 | 114 | 114 | 114 | 114 | 114 |
| Reserves | 11.03 | 11.26 | 11.51 | 11.68 | 11.66 | 11.43 | 9.51 | 9.5 | 11.51 | 7.41 | 7.25 | 7.24 |
| Borrowings | 11.54 | 11.79 | 11.58 | 11.55 | 11.55 | 11.53 | 11.53 | 11.53 | 11.53 | 1.34 | 1.34 | 1.34 |
| Other Liabilities | 10.75 | 48.07 | 24.27 | 21.27 | 20.73 | 20.56 | 20.63 | 20.63 | 10.51 | 10.49 | 0.4 | 0.41 |
| Total Liabilities | 147 | 185 | 161 | 159 | 158 | 158 | 156 | 156 | 148 | 133 | 123 | 123 |
| Fixed Assets | 13.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 10.75 | 21.15 | 15.12 | 6.64 | 6.61 | 6.45 | 6.45 | 6.45 | 6.45 | 6.45 | 6.45 | 6.45 |
| Other Assets | 123 | 164 | 146 | 152 | 151 | 151 | 149 | 149 | 141 | 127 | 117 | 117 |
| Total Assets | 147 | 185 | 161 | 159 | 158 | 158 | 156 | 156 | 148 | 133 | 123 | 123 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.2 | -2.59 | -18.07 | 4.04 | -0.06 | -0.04 | -1.9 | -0.04 | -7.72 | -0.03 | 0 | 0 |
| Investing | -2.21 | 2.78 | 6.33 | 8.64 | 0.07 | 0.03 | 1.91 | 0 | 0 | 0 | 0 | 0 |
| Financing | 0 | 0 | 11.99 | -13.1 | -0.06 | 0.01 | 0 | 0.04 | 7.78 | 0.08 | 0 | 0 |
| Net Cash Flow | -0.01 | 0.19 | 0.26 | -0.42 | -0.05 | 0.01 | 0.01 | 0 | 0.06 | 0.05 | 0 | 0 |
| Free Cash Flow | 2.2 | 10.33 | -18.07 | 4.04 | -0.06 | -0.04 | -1.9 | -0.04 | -7.72 | -0.03 | 0 | 0 |
| CFO/OP | 386 | -489 | — | 4,090 | 100 | 44 | 96 | 80 | 4,793 | 16 | 0 | — |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 943 | 317 | 1,398 | 566 | 13,630 | — | — | — | — | 55,845 | — | 55,845 |
| Inventory Days | 219 | 193 | 1,108 | 625 | 17,145 | — | — | — | — | 29,086 | — | — |
| Days Payable | 425 | 510 | 1,402 | 680 | 18,138 | — | — | — | — | 23,953 | — | — |
| Cash Conversion Cycle | 737 | 0.48 | 1,104 | 511 | 12,636 | — | — | — | — | 60,978 | — | 55,845 |
| Working Capital Days | 356 | 261 | 2,520 | 1,750 | 40,462 | — | — | — | — | 2,13,124 | — | 2,12,503 |
| ROCE % | 0.17% | 0.23% | 0.05% | 0.11% | -0.02% | -0.06% | -1.41% | -0.01% | -0.01% | -0.08% | -0.13% | 0% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sanguine Media insights
54 extracted metrics + investor summaries across FY10–FY27.
Documents
Frequently Asked Questions about Sanguine Media
What does Sanguine Media Ltd do?
Where is Sanguine Media Ltd (SANGUI) listed?
Which sector does Sanguine Media Ltd belong to?
Company Information
Sanguine Media operates as a media company. The Company manages various events, including entertainment shows, product launches, customer meets, training and development programs, concerts, and television events, as well as provides rural marketing services. Sanguine Media serves customers in India.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531898.md for Sanguine Media Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.